CytomX Therapeutics, Inc. ROE

The ROE as of November 2026 (TTM) for CytomX Therapeutics, Inc. (CTMX) is -38.46%

According to CytomX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -38.46%. This represents a change of 192.64% compared to the average of -13.14% of the last 4 quarters.

CytomX Therapeutics, Inc. (CTMX) Historical ROE (quarterly & annually)

How has CTMX ROE performed in the past?

The mean historical ROE of CytomX Therapeutics, Inc. over the last ten years is 1.88%. The current -38.46% ROE has changed -102.05% with respect to the historical average. Over the past ten years (40 quarters), CTMX's ROE was at its highest in in the December 2021 quarter at 5.71%. The ROE was at its lowest in in the December 2024 quarter at -4139.47%.

CytomX Therapeutics, Inc. (CTMX) ROE by Quarter and Year

Discovering the peaks and valleys of CytomX Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CytomX Therapeutics, Inc. (CTMX) Average ROE

How has CTMX ROE performed in the past?

The current ROE of CytomX Therapeutics, Inc. (CTMX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CytomX Therapeutics, Inc. (CTMX) ROE vs. Peers

How is CTMX’s ROE compared to its peers?

CytomX Therapeutics, Inc.’s ROE is greater than MacroGenics, Inc. (-31.27%), greater than Adagene Inc. (-29.09%), less than ADC Therapeutics S.A. (44.63%), greater than Celldex Therapeutics, Inc. (-52.36%), less than Nurix Therapeutics, Inc. (49.34%), less than Sutro Biopharma, Inc. (185.30%), greater than Pyxis Oncology, Inc. (-215.23%), greater than Xencor, Inc. (-21.29%), greater than Zymeworks Inc. (-72.07%), less than Veraxa Biotech Holding AG (0%),

Build a custom stock screener for CytomX Therapeutics, Inc. (CTMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytomX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CytomX Therapeutics, Inc. (CTMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CytomX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.